Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Mar 01, 2008 (Vol. 28, No. 5)

Scitalks: Smart People on Cool Topics

URL:www.scitalks.com/
  • LOTs of videos
  • Infomercials
Imagine grabbing a group of outstanding scientists, getting them together, and filming them talking about or demonstrating scientific principles. That’s part of the idea behind Scitalks: Smart People on Cool Topics, a media-rich site that will probably grab your attention for at least a few videos, if you visit it. Containing an amazing array of streaming media on topics spanning all of science, Scitalks is a site that must have an awful lot of bandwidth to serve its users. Visitors can select individual topics to pick items of interest to them. I picked Biochemistry and saw Judah Folkman discussing the discovery of angiogenesis inhibitors and Keith Campbell talking about the cloning of Dolly the sheep. On the downside, I also saw some material that was not a very thinly disguised infomercial for biochem products. Unfortunately, I guess, into each life a little rain must fall.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good


*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »